Close X
Attorney Spotlight

How does Justin Starling's former career as an urban planner inform his counsel to real estate developers? Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

FCPA: 2016 Year in Review & 2017 Enforcement Predictions

A review of trends and developments in FCPA as well as a look ahead into what to expect for 2017. This report aims at providing corporate leaders and companies with the knowledge they need to comply with the FCPA and avoid litigation in 2017.

Read now

Danielle Sloane Comments on Senate Finance Committee's Report on Stark Law

Modern Healthcare and Bloomberg BNA

Media Mentions

July 6, 2016

Bass, Berry & Sims attorney Danielle Sloane commented on the recent release of the Senate Finance Committee report critiquing Stark Law, more commonly known as the physician self-referral law, and its lack of flexibility. In a Modern Healthcare article, Danielle commented that, "one would hope this [report] is the signal of more to come," as Stark continues to evolve with the industry's shift to value-based care. For Bloomberg BNA, Danielle stated, "[t]he Finance Committee report seems to acknowledge the health-care industry's frustration with the complexities of the Stark law and the significant risks of inadvertently failing to comply."

Danielle was quoted in several articles regarding this topic, including:


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.